Towards Drug Repositioning: A Unified Computational Framework for Integrating Multiple Aspects of Drug Similarity and Disease Similarity
暂无分享,去创建一个
Ping Zhang | Fei Wang | Jianying Hu | Fei Wang | Jianying Hu | Ping Zhang
[1] R. Tagliaferri,et al. Discovery of drug mode of action and drug repositioning from transcriptional responses , 2010, Proceedings of the National Academy of Sciences.
[2] Temple F. Smith,et al. The statistical distribution of nucleic acid similarities. , 1985, Nucleic acids research.
[3] Donald A. Wilson,et al. ApoE-Directed Therapeutics Rapidly Clear β-Amyloid and Reverse Deficits in AD Mouse Models , 2012, Science.
[4] Bruce T. Volpe,et al. Generation of a unique small molecule peptidomimetic that neutralizes lupus autoantibody activity , 2011, Proceedings of the National Academy of Sciences.
[5] Alexander A. Morgan,et al. Discovery and Preclinical Validation of Drug Indications Using Compendia of Public Gene Expression Data , 2011, Science Translational Medicine.
[6] P. Sanseau,et al. Computational Drug Repositioning: From Data to Therapeutics , 2013, Clinical pharmacology and therapeutics.
[7] Cheng Zhu,et al. Drug repositioning for orphan diseases , 2011, Briefings Bioinform..
[8] Charles C. Persinger,et al. How to improve R&D productivity: the pharmaceutical industry's grand challenge , 2010, Nature Reviews Drug Discovery.
[9] Wentian Li,et al. STAT4 and the risk of rheumatoid arthritis and systemic lupus erythematosus. , 2007, The New England journal of medicine.
[10] Yongcui Wang,et al. Drug Repositioning by Kernel-Based Integration of Molecular Structure, Molecular Activity, and Phenotype Data , 2013, PloS one.
[11] Pankaj Agarwal,et al. Systematic Drug Repositioning Based on Clinical Side-Effects , 2011, PloS one.
[12] Fiona Crawford,et al. Nilvadipine antagonizes both Aβ vasoactivity in isolated arteries, and the reduced cerebral blood flow in APPsw transgenic mice , 2004, Brain Research.
[13] Joel Dudley,et al. Exploiting drug-disease relationships for computational drug repositioning , 2011, Briefings Bioinform..
[14] Katya Scheinberg,et al. Block Coordinate Descent Methods for Semidefinite Programming , 2012 .
[15] Guanghui Hu,et al. Human Disease-Drug Network Based on Genomic Expression Profiles , 2009, PloS one.
[16] Zhiyong Lu,et al. Pathway-based drug repositioning using causal inference , 2013, BMC Bioinformatics.
[17] Hao Ye,et al. Construction of Drug Network Based on Side Effects and Its Application for Drug Repositioning , 2014, PloS one.
[18] Yanli Wang,et al. PubChem: a public information system for analyzing bioactivities of small molecules , 2009, Nucleic Acids Res..
[19] Oakland J. Peters,et al. Predicting new indications for approved drugs using a proteochemometric method. , 2012, Journal of medicinal chemistry.
[20] Lin He,et al. Prediction of Drug-Target Interactions for Drug Repositioning Only Based on Genomic Expression Similarity , 2013, PLoS Comput. Biol..
[21] Patrick Aloy,et al. Recycling side-effects into clinical markers for drug repositioning , 2012, Genome Medicine.
[22] Zoran Obradovic,et al. Computational Drug Repositioning by Ranking and Integrating Multiple Data Sources , 2013, ECML/PKDD.
[23] R. Sharan,et al. PREDICT: a method for inferring novel drug indications with application to personalized medicine , 2011, Molecular systems biology.
[24] Fei Wang,et al. Generalized Cluster Aggregation , 2009, IJCAI.
[25] L. Cardon,et al. Use of genome-wide association studies for drug repositioning , 2012, Nature Biotechnology.
[26] Zhiyong Lu,et al. A new method for computational drug repositioning using drug pairwise similarity , 2012, 2012 IEEE International Conference on Bioinformatics and Biomedicine.
[27] A. Chiang,et al. Systematic Evaluation of Drug–Disease Relationships to Identify Leads for Novel Drug Uses , 2009, Clinical pharmacology and therapeutics.
[28] F. Pammolli,et al. The productivity crisis in pharmaceutical R&D , 2011, Nature Reviews Drug Discovery.
[29] Hsiang-Yuan Yeh,et al. Inferring drug-disease associations from integration of chemical, genomic and phenotype data using network propagation , 2013, BMC Medical Genomics.
[30] Xiang Li,et al. DOSim: An R package for similarity between diseases based on Disease Ontology , 2011, BMC Bioinformatics.
[31] S. Trent Rosenbloom,et al. Categorical Information in Pharmaceutical Terminologies , 2006, AMIA.
[32] Paul A Clemons,et al. The Connectivity Map: Using Gene-Expression Signatures to Connect Small Molecules, Genes, and Disease , 2006, Science.
[33] Lin He,et al. DRAR-CPI: a server for identifying drug repositioning potential and adverse drug reactions via the chemical–protein interactome , 2011, Nucleic Acids Res..
[34] Jing Wang,et al. Metformin activates an atypical PKC-CBP pathway to promote neurogenesis and enhance spatial memory formation. , 2012, Cell stem cell.
[35] P. Bork,et al. A side effect resource to capture phenotypic effects of drugs , 2010, Molecular systems biology.
[36] Gang Feng,et al. Disease Ontology: a backbone for disease semantic integration , 2011, Nucleic Acids Res..
[37] Yan Zhao,et al. Drug repositioning: a machine-learning approach through data integration , 2013, Journal of Cheminformatics.
[38] K. Śmietana,et al. Outlook for the next 5 years in drug innovation , 2012, Nature Reviews Drug Discovery.
[39] R. Jiang,et al. Integrating human omics data to prioritize candidate genes , 2013, BMC Medical Genomics.
[40] Alan F. Scott,et al. Online Mendelian Inheritance in Man (OMIM), a knowledgebase of human genes and genetic disorders , 2002, Nucleic Acids Res..
[41] G. Vriend,et al. A text-mining analysis of the human phenome , 2006, European Journal of Human Genetics.
[42] C E Lipscomb,et al. Medical Subject Headings (MeSH). , 2000, Bulletin of the Medical Library Association.
[43] Yadi Zhou,et al. Prediction of chemical-protein interactions: multitarget-QSAR versus computational chemogenomic methods. , 2012, Molecular bioSystems.
[44] David S. Wishart,et al. DrugBank 4.0: shedding new light on drug metabolism , 2013, Nucleic Acids Res..
[45] P. Bork,et al. Drug Target Identification Using Side-Effect Similarity , 2008, Science.